Team:Tuebingen/Project/Enzymes

From 2014.igem.org

(Difference between revisions)
Line 18: Line 18:
<p>
<p>
The &alpha;-<i>N</i>-acetylgalactosaminidase (NAGA) from <i>Elizabethkingia meningoseptica</i> is an enzyme which is capable of cleaving off the <i>N</i>-acetylgalactosamine residue of the A antigen. This enzyme consists of 448 amino acids and weights about 50.5 kDa. The structure is determined and can be found in the <a href=”http://www.rcsb.org/pdb/explore.do?structureId=2ixa”>RCSB Protein Data Base</a>.
The &alpha;-<i>N</i>-acetylgalactosaminidase (NAGA) from <i>Elizabethkingia meningoseptica</i> is an enzyme which is capable of cleaving off the <i>N</i>-acetylgalactosamine residue of the A antigen. This enzyme consists of 448 amino acids and weights about 50.5 kDa. The structure is determined and can be found in the <a href=”http://www.rcsb.org/pdb/explore.do?structureId=2ixa”>RCSB Protein Data Base</a>.
 +
 +
</p><img src="https://static.igem.org/mediawiki/2014/8/89/Tue2014_12IXA.jpg"style="width: 400px;">
 +
<p id="picTextCenter">Figure 1: &alpha;-<i>N</i>-acetylgalactosaminidase (2IXA) from <i>Elizabethkingia meningoseptica</i> </p>
 +
The NAGA uses an unusual mechanism to achieve its reaction. A catalytic NAD<sup>+</sup> accepts a hydride ion from C<sub>3</sub> of the <i>N</i>-acetylgalactosamine which leads to formation of an carbonyl group at this position. The carbonyl group at C<sub>3</sub> enables the abstraction of a proton at C<sub>2</sub> by stabilizing the temporary negative charge. The negative charge leads to the possibility to release the residual carbohydrates as an alcoholate and replacing them with an hydroxide ion. The catalytic cycle is finished by the regeneration of the NAD<sup>+</sup> through reduction of the carbonyl function at C<sub>3</sub>.  
The NAGA uses an unusual mechanism to achieve its reaction. A catalytic NAD<sup>+</sup> accepts a hydride ion from C<sub>3</sub> of the <i>N</i>-acetylgalactosamine which leads to formation of an carbonyl group at this position. The carbonyl group at C<sub>3</sub> enables the abstraction of a proton at C<sub>2</sub> by stabilizing the temporary negative charge. The negative charge leads to the possibility to release the residual carbohydrates as an alcoholate and replacing them with an hydroxide ion. The catalytic cycle is finished by the regeneration of the NAD<sup>+</sup> through reduction of the carbonyl function at C<sub>3</sub>.  
</p><img src="https://static.igem.org/mediawiki/2014/6/63/Tuebingen-NAGAMechanism1.jpg"style="width: 400px;">
</p><img src="https://static.igem.org/mediawiki/2014/6/63/Tuebingen-NAGAMechanism1.jpg"style="width: 400px;">
-
<p id="picTextCenter">Figure 1: Mechanism of the NAGA according to Liu et al.</p>
+
<p id="picTextCenter">Figure 2: Mechanism of the NAGA according to Liu et al.</p>
</p><img src="https://static.igem.org/mediawiki/2014/b/be/Tuebingen-NAGA-Mechanism2.jpg"style="width: 400px;">
</p><img src="https://static.igem.org/mediawiki/2014/b/be/Tuebingen-NAGA-Mechanism2.jpg"style="width: 400px;">
-
<p id="picTextCenter">Figure 2: Oxidation at C<sub>3</sub> improves the ability to deprotonate C<sub>2</sub></p>
+
<p id="picTextCenter">Figure 3: Oxidation at C<sub>3</sub> improves the ability to deprotonate C<sub>2</sub></p>
<p>
<p>
Line 33: Line 37:
</p><img src="https://static.igem.org/mediawiki/2014/1/11/Tue2014_2VNO.jpg"style="width: 400px;">
</p><img src="https://static.igem.org/mediawiki/2014/1/11/Tue2014_2VNO.jpg"style="width: 400px;">
-
<p id="picTextCenter">Figure 3: Endo-&beta;-galactosidase (2VNO) from <i>Clostridium perfringens</i> </p>
+
<p id="picTextCenter">Figure 4: Endo-&beta;-galactosidase (2VNO) from <i>Clostridium perfringens</i> </p>
</div>
</div>

Revision as of 23:49, 17 October 2014


Enzymes

Three different glycosidases were used during our project. All three enzymes target galactose and its derivatives like N-acetylgalactosamine in oligosaccharides and are therefore suitable for modification of the ABO-antigens on the surface of erythrocytes. The described enzymes are capable of cleaving off selectively the characteristic structures of the A and B antigen, thereby generating the H antigen and structures similar to this oligosaccharide, which is characteristic for blood type O.

The α-N-acetylgalactosaminidase (NAGA) from Elizabethkingia meningoseptica is an enzyme which is capable of cleaving off the N-acetylgalactosamine residue of the A antigen. This enzyme consists of 448 amino acids and weights about 50.5 kDa. The structure is determined and can be found in the RCSB Protein Data Base.

Figure 1: α-N-acetylgalactosaminidase (2IXA) from Elizabethkingia meningoseptica

The NAGA uses an unusual mechanism to achieve its reaction. A catalytic NAD+ accepts a hydride ion from C3 of the N-acetylgalactosamine which leads to formation of an carbonyl group at this position. The carbonyl group at C3 enables the abstraction of a proton at C2 by stabilizing the temporary negative charge. The negative charge leads to the possibility to release the residual carbohydrates as an alcoholate and replacing them with an hydroxide ion. The catalytic cycle is finished by the regeneration of the NAD+ through reduction of the carbonyl function at C3.

Figure 2: Mechanism of the NAGA according to Liu et al.

Figure 3: Oxidation at C3 improves the ability to deprotonate C2

α-Galactosidase (aGal) from Bacteroides fragilis is able to cleave off the terminal galactose residue of the B antigen. The enzyme is 589 amino acids long and weighs 66.12 kDa. The structure of the enzyme is not solved up to today. Kinetic properties were determined in the publication of Liu et al. 2007.

The endo-β-galactosidase (EABase) from Clostridium perfringens is able to accept the A and the B antigen as substrate and attacks the bond between galactose and N-acetylglucosamine. As a consequence, EABase releases the blood group trisaccharides and generates a precursor of the blood antigen H. The enzyme is 804 amino acids long and weights 91.25 kDa. The structure of the binding module of this enzyme is determined and can be accessed in the RCBS Protein Data Bank

Figure 4: Endo-β-galactosidase (2VNO) from Clostridium perfringens